Michio Painter
InvestorPartner at Ataraxia VC
Cambridge, Massachusetts
Writes $50K β $1M checks Β· typically $500K
Find your path to Michio
450 people in our graph share verified history with Michio β schools, employers, funds. One of them is your warm intro.
About
Michio Painter leads the UMZH Translational Medicine Accelerator at Spark Zurich and serves as an investment manager for the UZH Life Sciences Fund. His background spans neuroscience, immunology, and aging research, with experience as a biotech founder and CEO at Blue Tx, a seed-stage investor at Ataraxia VC, and academic accelerator leadership at UZH. His work focuses on translating early-stage biotech technologies from laboratory settings toward clinical and commercial application.
Experience
- Translational Medicine Accelerator (TMA) / Spark ZurichHead of the UMZH Translational Medicine Acceleratorcurrent2022 β presentZurich, Switzerland
- UZH Life Sciences FundInvestment Manager and Board Secretarycurrent2022 β presentZurich, Switzerland
- Joyance PartnersChief Science Partner2021 β 2022Somerville, Massachusetts, United States
- Joyance PartnersInvestment Partner2020 β 2021Cambridge, Massachusetts, United States
- Joyance PartnersVenture Partner2019 β 2020Cambridge, MA
- Blue TherapeuticsCo-Founder & CEO2014 β 2020Cambridge, MA
- XPRIZE FoundationPrize Developer2016Los Angeles, CA
- Howard Hughes Medical Institute/Harvard UniversityPost-doctoral Research Fellow2014 β 2015Cambridge, Massachusetts, United States
- Harvard UniversityPhD Student2009 β 2014Boston, MA
- Harvard Medical SchoolResearch Assistant2007 β 2009Boston, MA
- hayden-harnettDirector of Operations2006 β 2007Brooklyn, New York
Skills & more
+1 more
Cell CultureLanguages French
From Michio's professional profile.
Colleagues at Ataraxia VC
Frequently asked questions
- Who is Michio Painter?
- Michio Painter leads the UMZH Translational Medicine Accelerator at Spark Zurich and serves as an investment manager for the UZH Life Sciences Fund. His background spans neuroscience, immunology, and aging research, with experience as a biotech founder and CEO at Blue Tx, a seed-stage investor at Ataraxia VC, and academic accelerator leadership at UZH. His work focuses on translating early-stage biotech technologies from laboratory settings toward clinical and commercial application.
- Where does Michio Painter work?
- Michio Painter is Partner at Ataraxia VC.
- What check size does Michio Painter write?
- Michio Painter typically writes checks of $50K β $1M.
- Where did Michio Painter go to school?
- Michio Painter studied at Harvard University (PhD, Immunology); Middlebury College (BA, French).
Same school
Also attended Harvard University2,000
+ 1,994 more
Shared employers
Also worked at Joyance Partners27
+ 21 more
Also worked at XPRIZE Foundation28
+ 22 more
Also worked at Howard Hughes Medical Institute/Harvard University423
+ 417 more
Also worked at Harvard Medical School273
+ 267 more





















.png)













